Exelixis Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.73 | Buy/Sell | $130.51 | 8.56% | 11 | $333.65B |
| ROG | Roche Holding | Hold |
16
|
CHF227.50 | Buy/Sell | CHF307.83 | 19.78% | 9 | CHF183.65B |
| PFE | Pfizer | Outperform |
2
|
$28.82 | Buy/Sell | $32.87 | 5.83% | 6 | $163.31B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$978.21 | Buy/Sell | $961.26 | 7.34% | 8 | $105.53B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.55 | Buy/Sell | $58.15 | 21.21% | 10 | $90.31B |
| BAYN | Bayer | Hold |
5
|
29.33€ | Buy/Sell | 45.15€ | 2.28% | 4 | 28.81€B |
| 4523 | Eisai | Outperform |
18
|
¥6.86k | Buy/Sell | ¥9.58k | 22.38% | 0 | ¥1.97T |
| INCY | Incyte | Outperform |
9
|
$57.05 | Buy/Sell | $77.05 | 37.60% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$109.74 | Buy/Sell | $188.32 | 71.31% | 4 | $7.13B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$106.79 | Buy/Sell | $85.71 | 12.37% | 5 | $6.78B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$39.21 | Buy/Sell | $55.60 | 53.02% | 3 | $5.76B |